Financial Express
<img alt="" height="1" width="1" />
UPDATE 1-Furiex irritable bowel syndrome drug succeeds in large trials
Reuters
(Adds share movement). By Bill Berkrot. Feb 4 (Reuters) - Shares of Furiex Pharmaceuticals Inc more than doubled in value after the company said its experimental drug significantly alleviated diarrhea and abdominal pain associated with irritable bowel ...
Furiex Shares Double on Irritable Bowel Drug Trial SuccessBloomberg
Positive Results Observed for Eluxadoline in IBS-d TrialsMonthly Prescribing Reference
Furiex irritable bowel syndrome drug succeeds in large trialsReuters UK
RTT News -WallStreetPR -Wall Street Journal
all 23 news articles »
More...